Muhammad Asif Arain | Functional food | Best Researcher Award

Posted on by Research Data Analysis

Dr. Muhammad Asif Arain | Functional food | Best Researcher Award

Lasbela University of Agriculture Water and Marine Sciences | Pakistan

PROFILE VERIFIED

Scopus

👋 INTRODUCTION

Dr. Muhammad Asif Arain is an esteemed veterinary scientist and academician at Lasbela University of Agriculture, Water and Marine Sciences, Pakistan. Specializing in Animal Product Technology, he has dedicated his career to advancing veterinary sciences, focusing on animal product safety, quality, and innovation.

🎓 EARLY ACADEMIC PURSUITS

Dr. Arain began his academic journey at Sindh Agriculture University, Tandojam, where he earned his Doctor of Veterinary Medicine (DVM) degree with first-class honors. He continued to excel by completing an M.Sc. (Hons) in Animal Product Technology with distinction, and he is currently pursuing his PhD in the same field, reflecting his ongoing commitment to learning and research.

💼 PROFESSIONAL ENDEAVORS

With over a decade of experience, Dr. Arain has served as Assistant Professor and Lecturer at LUAWMS. His practical experience includes veterinary officer roles in significant development projects funded by the United Nations and regional rural support programs. He has also contributed as a trainee in vaccine production and diagnostics, enhancing his expertise in veterinary medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Arain’s research focuses on the biochemical, microbiological, and nutritional properties of animal products, especially camel and goat milk. He has worked on cutting-edge projects related to milk biodiversity, poultry immunity, and antimicrobial applications of nanoparticles, supported by major national research foundations.

📈 IMPACT AND INFLUENCE

He has published 98 research papers with over 3,300 citations and a total impact factor of 162, demonstrating his substantial contribution to veterinary science. His work has influenced both academia and industry, fostering improvements in animal health and product quality.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Arain’s recent publications include studies on the anti-diabetic effects of camel milk, nutritional supplementation in poultry, and advanced molecular analyses of dairy products. These works appear in high-impact journals, showcasing his research’s relevance and global reach.

🏆 HONORS & AWARDS

Throughout his career, Dr. Arain has been recognized for academic excellence, securing prestigious research funding, and assuming leadership roles in research management and commercialization, underscoring his dedication to advancing veterinary sciences.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As a leading expert in veterinary product technology, Dr. Arain is poised to further elevate the field with his PhD research and active involvement in teaching, research innovation, and industry collaboration. His efforts promise ongoing benefits for animal agriculture and health sectors.

✍️ FINAL NOTE

Dr. Muhammad Asif Arain is a committed scholar and researcher whose work bridges scientific discovery and practical applications. His ongoing contributions continue to enhance veterinary education, research, and animal product technologies in Pakistan and beyond.

📚 SELECTED PUBLICATIONS

  • Exploring the anti-diabetic properties of camel milk: effects on blood glucose, antioxidant defense, and organ histo-morphological features in rabbits

    • Authors: M.A. Arain, Muhammad Asif; G.B. Khaskheli, Gul Bahar; G.S. Barham, Ghulam Shabir; B.O. Almutairi, Bader Obaid; I.B. Marghazani, Illahi Bakhash

    • Journal: Journal of Molecular Histology

    • Year: 2025

  • Nutraceutical potential of essential oils in dairy animal diets: challenges and opportunities

    • Authors: A.A. Aboamer, A. A.; H.M. Ebeid, Hossam M.; F. Siddique, Faisal; M.A. Arain, Muhammad Asif; F.U. Hassan, F. Ul

    • Journal: (Not specified in your data)

    • Year: (Not specified in your data)

  • Regulation of energy metabolism by non-coding RNAs in livestock species: a review

    • Authors: F.U. Hassan, F. Ul; M. Safdar, Muhammad; M. Younus, Muhammad; M.A. Arain, Muhammad Asif

    • Journal: (Not specified)

    • Year: (Not specified)

  • An in-depth overview of the nutritional advantages of medicinal plant supplementation in poultry feed

    • Authors: A.U. Rehman, Abdur Ur; J.A. Buzdar, Jameel Ahmed; M.A. Arain, Muhammad Asif; M. Arslan, Muhammad; C. Zhou, Cunshan

    • Journal: (Not specified)

    • Year: (Not specified)

  • Nutrigenomic Potential of Mineral Nano-Particles to Modulate Poultry Health and Performance

    • Authors: A. Arsalan, Abdullah; A.U. Rehman, Abdur Ur; H. Younus, Hina; J.A. Buzdar, Jameel Ahmed; X. Qi, Xianghui

    • Journal: (Not specified)

    • Year: (Not specified)

  • Effects of in ovo supplementation of selenium (Se) and zinc (zn) on hatchability and production performance of broiler chickens

    • Authors: F. Nabi, Fazul; M.A. Arain, Muhammad Asif; M.F. Hassan, Mohammad Farooque; M.H. Almutairi, Mikhlid Hammad; J.A. Buzdar, Jameel Ahmed

    • Journal: Journal of Comparative Physiology B Biochemical Systemic and Environmental Physiology

    • Year: 2024

  • Lactoferrin’s role in modulating NF-κB pathway to alleviate diabetes-associated inflammation: A novel in-silico study

    • Authors: M.A. Arain, Muhammad Asif; G.B. Khaskheli, Gul Bahar; G.S. Barham, Ghulam Shabir; I.B. Marghazani, Illahi Bakhash

    • Journal: Heliyon

    • Year: 2024

 

Martin Hegen | Human Dose Predictions | Best Researcher Award

Posted on by Research Data Analysis

Dr. Martin Hegen | Human Dose Predictions | Best Researcher Award

Pfizer | United States

PUBLICATION PROFILE

Scopus

🧑‍🔬 INTRODUCTION

Dr. Martin Hegen is a highly accomplished Research Fellow at Pfizer, widely respected for his leadership and scientific expertise in immunology and inflammation. With more than 20 years of experience in the pharmaceutical industry, Dr. Hegen has made substantial contributions to drug discovery and development, driving projects from portfolio entry to clinical proof-of-concept. His work bridges rigorous scientific research with strategic leadership, ensuring high-quality results and consistent compliance with regulatory and ethical standards.

🎓 EARLY ACADEMIC PURSUITS

Dr. Hegen began his academic journey in Germany, earning a Ph.D. in Immunology magna cum laude from Johannes Gutenberg-University of Mainz in 1993, after receiving an M.Sc. in Biology in 1988. He then undertook a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, where he explored critical signaling mechanisms in T cell activation involving CD26 and CD45 isoforms. This foundational research into immune system regulation shaped his scientific perspective and laid the groundwork for a successful career in translational immunology.

🧪 PROFESSIONAL ENDEAVORS

Dr. Hegen’s professional career spans over two decades of increasing responsibility and impact. He joined Wyeth Research in 2001, focusing on inflammatory diseases and advancing several therapeutic antibody programs. Following Pfizer’s acquisition of Wyeth in 2009, Dr. Hegen transitioned into the Inflammation & Immunology Research Unit at Pfizer, where he held several key roles including Senior Principal Scientist, Associate Research Fellow, and currently, Research Fellow. Throughout these positions, he provided scientific and managerial leadership for autoimmune disease models, led project teams, and mentored research scientists, including Ph.D.-level staff. He has directed collaborative programs across international sites and partnered with academic and biotech institutions to accelerate therapeutic innovation.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Hegen’s scientific contributions are focused on autoimmune and inflammatory diseases, such as rheumatoid arthritis, lupus, psoriasis, inflammatory bowel disease, and multiple sclerosis. His expertise includes the use of gene-deficient mice and other advanced preclinical models to validate therapeutic targets. He has led efforts in both biologic and small molecule programs, guiding lead molecule selection and supporting successful clinical trials. His deep understanding of disease pathogenesis and experience with regulatory filings has been vital in bringing investigational drugs like Tofacitinib through the pipeline.

🌍 IMPACT AND INFLUENCE

Throughout his career, Dr. Hegen has left a lasting impact through both scientific contributions and leadership. Under his supervision, multiple scientists have received Individual Performance Awards. His strategic guidance and scientific rigor have influenced key decision-making processes, from target prioritization to portfolio entry and in-licensing evaluations. His work on clinical programs such as Ozoralizumab and other Janus kinase inhibitors has directly shaped Pfizer’s therapeutic portfolio in immunology.

📚 ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Hegen has a strong publication record and has served on editorial boards for leading journals such as The Journal of Immunology, Inflammation Research, and Journal of Leukocyte Biology. He has contributed peer reviews and editorial oversight for decades, influencing scholarly standards in immunology and inflammation research. His expertise is frequently sought after in reviewing cutting-edge scientific findings, and he has held roles as associate editor and invited chairman at international immunology conferences.

🏆 HONORS & AWARDS

Dr. Hegen’s achievements have been recognized by prestigious organizations. He received a postdoctoral fellowship from the German Research Society and was honored with Wyeth’s “Above and Beyond Award” in 2003. He was selected for elite leadership training programs at Wyeth (Eagles Program) and Pfizer (Cornerstones of Management), highlighting his commitment not only to science but also to cultivating leadership excellence.

🧬 PATENTS

Dr. Hegen is listed as an inventor on multiple patents, emphasizing his role in therapeutic innovation. These include methods for using antibodies against IL-22, anti-M-CSF antibodies for treating inflammatory disorders, and the development of modified single-domain antibody molecules targeting TNF-α. His patents contribute to the intellectual property backbone supporting Pfizer’s clinical development programs.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Martin Hegen’s legacy is defined by scientific excellence, impactful leadership, and the successful advancement of multiple therapeutic programs. His work has significantly contributed to the understanding and treatment of complex autoimmune diseases. As an active member of the American College of Rheumatology and American Association of Immunologists, he continues to shape the future of immunology research. Dr. Hegen remains committed to mentoring the next generation of scientists and driving forward innovations that will improve patient care worldwide.

📝 FINAL NOTE

Dr. Martin Hegen represents the highest standard of professionalism, scientific insight, and collaborative leadership in biomedical research. His career reflects a rare combination of deep academic training, pharmaceutical innovation, and strategic execution. As immunology continues to evolve, Dr. Hegen’s enduring influence will be felt in both clinical outcomes and the growing body of scientific knowledge advancing human health.

 📚 TOP NOTES PUBLICATIONS

Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration

    • Authors: Kenneth F. Baker, J. Spierings, Martin Brom, Stephen Oliver, Richard Veselý

    • Journal: Rheumatology (exact journal not specified, likely from context)

    • Year: (Not explicitly provided, but likely 2023 or 2024)

RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells

    • Authors: Céline Mortier, Eric Gracey, Julie Coudenys, Dirk Elewaut, Koen J.T. Venken

    • Journal: Rheumatology

    • Year: 2023

A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894)…
(Truncated title: “…Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6⁺ T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation”)

    • Authors: Wei Li, Kimberly K. Crouse, Jennifer Alley, Michael S. Vincent, Gabriel Berstein

    • Journal: Journal of Pharmacology and Experimental Therapeutics

    • Year: 2023

Studies with neutralizing antibodies suggest CXCL8-mediated neutrophil activation is independent of C-C motif chemokine receptor-like 2 (CCRL2) ligand binding function

    • Authors: Zhenwei Su, Jonathan M. Brooks, Jeffrey W. Pelker, Alfredo Darmanin Sheehan, Joseph J. Brennan

    • Journal: PLoS ONE

    • Year: 2023

Maisa Araujo | Entomology | Best Researcher Award

Posted on by Research Data Analysis

Dr. Maisa Araujo | Entomology | Best Researcher Award

Fiocruz Rondônia | Brazil

PUBLICATION PROFILE

Scopus

Orcid

Dr. Maisa Araujo⚡🌍

INTRODUCTION 🌟

Dr. Maisa Araujo is a distinguished researcher and professor with a strong academic and research background, specializing in molecular biology and entomology, particularly in the context of malaria transmission. With a comprehensive education and postdoctoral training, she has contributed extensively to understanding parasitic diseases and vector biology. She is an active member of various global research projects and has earned recognition for her work in tropical diseases and vector control.

EARLY ACADEMIC PURSUITS 📚

Dr. Araujo’s journey began with a degree in Biological Sciences from the Faculty of Education of Porto Velho in Brazil, followed by a Master’s and PhD in Experimental Biology at the University of Rondônia. Her academic career laid the foundation for a deep focus on parasitology, entomology, and molecular biology. Through these early academic pursuits, Dr. Araujo set the stage for her future groundbreaking work in malaria research.

PROFESSIONAL ENDEAVORS 👩‍🔬

Throughout her career, Dr. Araujo has held numerous prestigious positions in both academic and research settings. As an associate professor and researcher at the Translational and Clinical Research Lab, Dr. Araujo has led major research initiatives and provided expertise in vector biology and malaria transmission. Her role as a Principal Investigator and Co-Investigator on various internationally funded grants has allowed her to contribute substantially to the global understanding of malaria transmission and its control.

CONTRIBUTIONS AND RESEARCH FOCUS  ON Entomology🔬

Dr. Araujo’s research primarily focuses on the molecular biology of malaria vectors, specifically the interactions between parasites and their mosquito vectors. One of her most significant contributions is the establishment of the first free-mating colony of Anopheles darlingi in Brazil, which serves as a platform for studying malaria vector biology and testing drugs to block transmission. Her laboratory has developed crucial tools for vector-pathogen interaction studies, with ongoing projects focused on liver-stage drug assays for Plasmodium vivax.

IMPACT AND INFLUENCE 🌍

Dr. Araujo’s research has had a significant impact on the study of malaria, particularly in the Amazon region. By creating laboratory colonies of malaria vectors and advancing the study of the vector-pathogen interaction, her work has opened up new possibilities for malaria control. Her involvement in multiple high-profile international research projects further highlights her influence and dedication to advancing public health, particularly in endemic regions.

ACADEMIC CITATIONS AND PUBLICATIONS 📑

With numerous peer-reviewed publications, Dr. Araujo has made important contributions to the fields of parasitology, entomology, and tropical medicine. Her research has been widely cited and continues to shape the scientific discourse on malaria transmission and control strategies. She has published in top-tier journals and participated in global conferences, sharing her findings and collaborating with experts worldwide.

HONORS & AWARDS 🏆

Dr. Araujo has received several prestigious honors and awards throughout her career. Notably, she won the “Young Trajectories in Malariology Award” in 2022 from Instituto Oswaldo Cruz, Fiocruz, Brazil. She was also awarded the “Best Presentation Award” at the 9th International Conference on Plasmodium vivax Research in 2025. These accolades reflect her exceptional contributions to the field of malaria research and public health.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Dr. Araujo’s work has established a lasting legacy in the fight against malaria. As she continues her research, her future contributions are expected to push the boundaries of malaria control and drug development. Through innovative techniques like the establishment of vector colonies and hepatocyte infection assays, Dr. Araujo aims to accelerate the discovery of new transmission-blocking compounds and treatments for malaria.

FINAL NOTE 💡

Dr. Araujo’s journey, from her early academic pursuits to her groundbreaking research in malaria transmission, demonstrates her dedication and passion for scientific advancement. Her contributions continue to shape the future of malaria research, particularly in endemic regions like the Amazon. As she continues to lead high-impact research initiatives, her influence in the field will undoubtedly continue to grow, bringing us closer to solutions in the battle against malaria.

TOP NOTES PUBLICATIONS 📚

Blood Source and Anesthetics Effects on the Maintenance of Anopheles darlingi in the Lab-Rearing Condition

Authors: José Daniel Costa Pontual, Natália Vitória Coelho, Najara Akira Costa dos Santos, Alessandra da Silva Bastos, Jéssica Evangelista Araújo, Alice Oliveira Andrade, Jansen Fernandes Medeiros, Maisa da Silva Araujo
Journal: Insects
Year: 2025

Timeless noncoding DNA contains cell-type preferential enhancers important for proper Drosophila circadian regulation

Authors: Dingbang Ma, Pranav Ojha, Albert D. Yu, Maisa S. Araujo, Weifei Luo, Evelyn Keefer, Madelen M. Díaz, Meilin Wu, William J. Joiner, Katharine Abruzzi et al.
Journal: Proceedings of the National Academy of Sciences
Year: 2024

Effects of Carbohydrate Intake on Anopheles darlingi and Anopheles deaneorum Fitness under Lab-Reared Conditions

Authors: Najara A. C. Santos, Mirilene M. Martins, Alice O. Andrade, Alessandra Bastos, José Daniel Costa Pontual, Jéssica Araújo, Marina L. Rocha, Jansen F. Medeiros, Maisa S. Araujo
Journal: Insects
Year: 2024

Transmission-reducing and -enhancing monoclonal antibodies against Plasmodium vivax gamete surface protein Pvs48/45

Authors: Geetha P. Bansal, Maisa da Silva Araujo, Yi Cao, Emily Shaffer, Jessica Evangelista Araujo, Jansen Fernandes Medeiros, Clifford Hayashi, Joseph M. Vinetz, M.D., Nirbhay Kumar
Journal: Infection and Immunity
Year: 2024

Case Report: Plasmodium vivax Sporozoite Melanization in the Midgut and Salivary Gland of the Malaria Vector Anopheles darlingi

Authors: Najara Akira Costa dos Santos, Alessandra da Silva Bastos, Jéssica Evangelista Araújo, José Daniel Costa Pontual, Jansen Fernandes Medeiros, Joseph Michael Vinetz, Maisa da Silva Araujo
Journal: The American Journal of Tropical Medicine and Hygiene
Year: 2024

George Chimowa | Disease diagnosis | Excellence in Research

Posted on by Research Data Analysis

Dr. George Chimowa | Disease diagnosis | Excellence in Research

Botswana International University of Science and Technology | Botswana

Publication Profile

Google Scholar

DR. GEORGE CHIMOWA – NANOMATERIALS PHYSICIST & RESEARCH LEADER ⚛️🔬

INTRODUCTION 📚

Dr. George Chimowa is a distinguished physicist specializing in nanomaterials for energy and health applications. With over 13 years of academic experience and a strong background in both research and industry, he has made significant contributions to the field of nanotechnology, electronic transport, and material sciences. Currently serving as a Senior Lecturer at the Botswana International University of Science and Technology (BIUST), he leads groundbreaking research that bridges fundamental physics with applied technological advancements.

EARLY ACADEMIC PURSUITS 🎓

Dr. Chimowa’s journey into physics began with a BSc (Hons) in Physics from the National University of Science and Technology, Zimbabwe. He later pursued an MSc in Physics at the University of the Witwatersrand, focusing on synthesis and characterization of nanodiamond films. His academic excellence led him to a PhD in Physics (2011-2015) at the University of the Witwatersrand, where his research explored dynamic electrical transport in carbon nanotubes and nanodiamond films.

PROFESSIONAL ENDEAVORS 💼

Dr. Chimowa’s career spans both academia and industry, reflecting his versatility in applying scientific expertise to real-world challenges:

  • Senior Lecturer (March 2021 – Present), Botswana International University of Science and Technology
  • Lecturer (2019 – 2021), Botswana International University of Science and Technology
  • Postdoctoral Researcher (2016 – 2017), CNRS, Toulouse, France – Focused on nanomaterials for disease diagnosis under the EU Graphene Project.
  • Postdoctoral Researcher (2015 – 2016), CSIR, South Africa – Developed nanomaterials for gas sensing in the mining sector.
  • Electronic Engineer (2009), World Processing Devices, South Africa – Designed electronic mining safety equipment.
  • Broadcast Engineer (2002 – 2009), CII Broadcasting (South Africa) & Zimbabwe Broadcasting Corporation – Managed broadcasting infrastructure and training.
  • High School Teacher (2000 – 2008), Zimbabwe & Namibia – Taught Mathematics and Physics at Advanced and Ordinary Levels.

CONTRIBUTIONS AND RESEARCH FOCUS  ON DISEASE DIAGNOSIS🔬

Dr. Chimowa’s research focuses on nanomaterials for energy and health applications, with particular expertise in:

  • Carbon-based nanomaterials for electronic and sensing applications.
  • Electrical transport properties of nanostructured materials.
  • Graphene and nanotube-based sensors for disease diagnosis.
  • Device fabrication using advanced lithographic techniques.

His leadership in research is evident in his supervision of 2 PhD students and 3 MSc students, ensuring the next generation of scientists is well-equipped to advance nanotechnology applications.

IMPACT AND INFLUENCE 🌍

Dr. Chimowa’s work has had a profound impact on both fundamental physics and applied materials science. His innovations in electronic transport phenomena have influenced the development of next-generation nano-electronic devices. As a reviewer for several international journals, he actively contributes to the scientific community by maintaining research integrity and quality.

ACADEMIC CITATIONS AND PUBLICATIONS 📝

Dr. Chimowa has an impressive 22 peer-reviewed journal publications, with 11 as the first author. Notable publications include:

  1. New Volatile Organic Compounds from the Exhaled Breath of Active Tuberculosis Patients – Nature Scientific Reports (2025).
  2. Converting Ambipolar Double-Walled Nanotube Bundles to Unipolar CNT FET Devices – Phys. Status Solidi A (2023).
  3. Improving Gas Sensing Properties of MWCNTs by Vanadium Oxide Filling – Sensors and Actuators B (2017).
  4. Temperature-Dependent Diffusive to Ballistic Transition in DWCNTs – Applied Physics Letters (2014).
  5. Origin of Conductive Crossover in MWCNTs Filled by Iron – Physical Review B (2011).

More publications can be accessed via Google Scholar.

HONORS & AWARDS 🏅

Dr. Chimowa’s research excellence has been recognized with several prestigious grants and awards, including:

  • African Research Initiative for Scientific Excellence (ARISE-PP) Grant – €443,920 (2022-2027).
  • Young Researcher Establishment Fund (YREF) – ZAR 600,000 (2015-2016).
  • Golden Key International Research Grant – USD $1,000 (2013).
  • Staff Initiation Grant, BIUST – BWP 200,000 (2019-2021).

FINAL NOTE ✨

With a unique blend of academic expertise, research leadership, and industrial experience, Dr. Chimowa continues to shape the future of nanotechnology and material science. His mentorship of postgraduate students, extensive publication record, and cutting-edge research solidify his position as a leading physicist in Africa and beyond.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Dr. Chimowa’s legacy lies in his pioneering work in nanomaterials, his dedication to advancing scientific knowledge, and his commitment to mentoring future researchers. As a principal investigator on major international projects, he is set to drive innovation in nanotechnology for years to come, impacting both academia and industry.

TOP NOTES PUBLICATIONS 📚

Anisotropic three-dimensional weak localization in ultrananocrystalline diamond films with nitrogen inclusions
    • Authors: LH Willems van Beveren, DL Creedon, N Eikenberg, K Ganesan, …
    • Journal: Physical Review B
    • Year: 2020
The effect of metal-contacts on carbon nanotube for high frequency interconnects and devices
    • Authors: G Chimowa, S Bhattacharyya
    • Journal: AIP Advances
    • Year: 2014
Realizing one-dimensional quantum and high-frequency transport features in aligned single-walled carbon nanotube ropes
    • Authors: S Ncube, G Chimowa, Z Chiguvare, S Bhattacharyya
    • Journal: Journal of Applied Physics
    • Year: 2014
Observation of impedance oscillations in single-walled carbon nanotube bundles excited by high-frequency signals
    • Authors: G Chimowa, S Ncube, S Bhattacharyya
    • Journal: Europhysics Letters
    • Year: 2015
High-frequency electrical transport in nitrogen incorporated nano-crystalline diamond films in the GHz regime
    • Authors: G Chimowa, RM Erasmus, S Bhattacharyya
    • Journal: Europhysics Letters
    • Year: 2015
Converting Ambipolar Double‐Walled Nanotube Bundles to Unipolar Carbon Nanotube Field‐Effect Transistor Devices by Inner Functionalization
    • Authors: G Chimowa, E Flahaut, VR Sodisetti, S Bhattacharyya
    • Journal: physica status solidi (a)
    • Year: 2023